|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 877.6 INR | -0.10% |
|
+0.59% | +29.02% |
| 05-28 | Jenburkt Pharmaceuticals Limited Announces Board Retirements | CI |
| 05-28 | Jenburkt Pharmaceuticals Limited Announces Dividend | CI |
Jenburkt Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2022. For the first quarter, the company reported sales was INR 311.32 million compared to INR 271.8 million a year ago. Revenue was INR 322.75 million compared to INR 283.75 million a year ago.
Net income was INR 59.53 million compared to INR 46.51 million a year ago. Basic earnings per share from continuing operations was INR 12.97 compared to INR 10.13 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.02% | 46.39M | |
| +56.89% | 823B | |
| +39.52% | 627B | |
| -6.55% | 353B | |
| +15.99% | 320B | |
| +7.92% | 295B | |
| +13.74% | 239B | |
| +13.83% | 220B | |
| -0.49% | 219B | |
| +7.94% | 167B |
JENBURKT PHARMACEUTICALS LIMITED 
